Order of the Supreme Court of India in the matter of All India Drug Action Network & Others Vs Union of India Ministry of Health & Others dated 13/09/2023. Additional Solicitor General informed the Supreme Court that the Union government would place an update affidavit on the record setting out the mechanism for the price control of life saving and essential drugs.

The bench of Justice Satish Chander Sharma and Justice Sanjeev Narula of the Delhi High Court, September 1, 2023 directed Union of India to furnish the reasons as to why the drug ‘Nimesulide’ has not been banned, and deliberations undertaken in this regard.

The Department of Pharmaceuticals (DoP) has notified the National Policy on Research & Development and Innovation in the Pharma-Med Tech Sector in India with reforms in terms of regulatory framework and streamlining processes reducing the approval timelines, incentivising investment in innovation and creation of an enabling ecosystem for inn

The Global Action Plan on HIV drug resistance 2017–2021 provided a comprehensive framework for global and country action and outlined a package of interventions and resources to guide the collective response to HIV drug resistance.

The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs).

Trafficked medical products kill almost half a million sub-Saharan Africans every year, and action is needed to stem the flow, the United Nations Office on Drugs and Crime (UNODC) states in its new threat assessment report.

The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR.

Order of the Supreme Court of India in the matter of Cure SMA Foundation of India & Others Vs Union of India & Others dated 05/12/2022.

The petition filed in the nature of Public Interest Litigation (PIL) requested the Supreme Court to pass a writ in the nature of mandamus directing the government of India to completely exempt drugs for treatment of rare diseases from the levy of IGST, CGST, SGT and custom duty.

Analysis by the UN ahead of World AIDS Day reveals that inequalities are obstructing the end of AIDS. On current trends the world will not meet agreed global targets on AIDS. But the new UNAIDS report, Dangerous Inequalities, shows that urgent action to tackle inequalities can get the AIDS response on track.

The Ministry of Health and Family Welfare on 17th November 2022, has published the Drugs (Eighth Amendment) Rules, 2022 to further amend the Drugs Rules, 1945.